The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews.
“Today’s rollout of Elsa is ahead of schedule and under budget, thanks to the collaboration of our in-house experts across the centers,” said FDA Commissioner Marty Makary.
The agency said it is already using Elsa to expedite clinical protocol reviews, shorten the time needed for scientific evaluations, and pinpoint high-priority inspection targets.
Once the FDA receives an application for a potential drug approval, it has six to 10 months to make a decision.
Elsa assists with reading, writing, and summarizing tasks. It can summarize adverse events to support safety profile assessments of drugs and rapidly compare packaging inserts.
“Elsa offers a secure platform for FDA employees to access internal documents while ensuring all information remains within the agency. The models do not train on data submitted by regulated industry, safeguarding the sensitive research and data handled by FDA staff,” the FDA said.
In May, the regulator said it would fully integrate AI by June 30, following an experimental run.
—Puyaan Singh, Reuters
Melden Sie sich an, um einen Kommentar hinzuzufügen
Andere Beiträge in dieser Gruppe
From family photos in the cloud to email archives and social media accounts, the digital lives of Americans are extensive and growing.
According to recent studies by the password managem
A dozen years after its launch, fintech company Chime rang the bell this morning at the Nasdaq MarketSite in Times Square to ce
It hits at a certain time in the afternoon, when a familiar craving strikes. You walk to the kitchen. The satisfying sound of a can cracking, the hiss of bubbles. It’s time for a “fridge cigarette
Many developers find that AI programming assistants have made writing code easier than ever. But maintaining the infrastructure that actually runs that code remains a challenge, requiring engineer
Fraudulent job applications have become a serious issue in the era of
With the first family actively engaged in memecoin ventures, speculation about the future of cryptocurrency has never been hotter. Laura Shin, crypto expert and host of the podcast Unchained
